Crossmark

Fulminant type 1 diabetes mellitus induced by tislelizumab in a patient with lung adenocarcinoma: a case report

Published Online: 2026-01-28

Authors

Feng, Yuanzhen

Cheng, Xiankang

Liu, Jiao

Qi, Jun

Han, Limin https://orcid.org/0000-0002-1804-1148
Funding

Funding for this research was provided by:

The Science and Technology Planning Project of Changshou District of China (CSKJ2024028)
License Information

Text and Data Mining valid from 2026-01-28

Version of Record valid from 2026-02-20
More Information

Article History

Received: 28 October 2025

Accepted: 23 December 2025

First Online: 28 January 2026

Declarations

:

: Ethics approval was acquired.

: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: The authors declare no competing interests.

Document is current